Non-small cell lung cancer is a common type of lung cancer, accounting for over 85% of cases. Current clinical approaches to this disease primarily involve surgery, combined with radiotherapy, chemotherapy, targeted therapy, and immunotherapy. In the past, open chest surgery was the primary method for lung cancer surgery, but it was associated with significant trauma and numerous complications, leading to a decrease in patients' quality of life and certain limitations. With the rapid development of modern surgical techniques, endoscopic technology has shown promising results in the surgical treatment of lung cancer. Video-assisted thoracoscopic surgery (VATS) for lung cancer offers the advantages of minimally invasive procedures, reduced bleeding, and faster recovery. In recent years, it has gained widespread clinical use and demonstrated high effectiveness and safety. This article primarily discusses the outcomes of VATS in the treatment of non-small cell lung cancer in elderly patients.

Jiajun Song. Efficacy of Thoracoscopic Surgery in Elderly Patients with Non-Small Cell Lung Cancer. Frontiers in Medical Science Research (2023) Vol. 5, Issue 11: 46-50. https://doi.org/10.25236/FMSR.2023.051107.

[1] Du H, Tong Y, Wang M. Epidemiological characteristics and prognostic factors of non-small cell lung cancer in Shanxi region from 2015 to 2019. Tumor Research and Clinical. 2022; 34(1):47-50.

[2] Zhai Z, Chen F, Qiao H. Comparative analysis of the efficacy of different surgical methods in non-small cell lung cancer patients. Practical Journal of Cancer. 2023; 38(5):855-858.

[3] Zhou B, An S, Wang J, et al. Clinical efficacy of video-assisted thoracoscopic surgery for the treatment of non-small cell lung cancer in elderly patients. Chinese and Foreign Medical Research. 2023; 42(11):91-94, 99.

[4] Ji X, Huang Z, Jing Y, et al. Clinical efficacy of video-assisted thoracoscopic surgery for non-small cell lung cancer. Chinese Health Standard Management. 2023; 14(5):95-98.

[5] Zhou Z, Yang Y. Systematic review and meta-analysis of the efficacy of television thoracoscopy and open chest surgery in the treatment of central non-small cell lung cancer. Jiangxi Medicine. 2023; 58(2):176-182.

[6] Zhao K, Che W. Clinical comparative study of single-port thoracoscopic surgery and two-port thoracoscopic surgery in the treatment of non-small cell lung cancer. Chinese Practical Medicine. 2023; 18(9):17-20.

[7] Liu J, Shang Z, Hao L, et al. Value of single-port and three-port full thoracoscopic entry surgery in the treatment of early non-small cell lung cancer. Shenzhen Journal of Integrative Traditional Chinese and Western Medicine. 2023; 33(7):11-14.

[8] Zhou X, Zheng S, Zhang J. Influence of single-port thoracoscopic surgery on postoperative serum trauma response and tumor micro-metastasis in elderly non-small cell lung cancer patients. Journal of Chinese Gerontology. 2022;42(12):2938-2941.

[9] Chen J, Meng J, Zhao Y, et al. Analysis of risk factors for postoperative recurrence and metastasis in patients with non-small cell lung cancer treated by minimally invasive thoracic surgery. Journal of Chinese Medicine. 2023;29(3):343-347.

[10] Pan H, Zhang W. Efficacy observation of thoracoscopic lung segment resection in the treatment of early non-small cell lung cancer and Logistic regression analysis of prognosis factors. Heilongjiang Medicine and Pharmacy. 2023;46(4):184-187.

[11] Tian Y, Guo J. Risk factors for complications after thoracoscopic lung resection for non-small cell lung cancer. Modern Scientific Instruments. 2023;40(4):124-128.

[12] Yang D, Zhou S, Hu Z, et al. Construction of a risk prediction model for postoperative pulmonary complications in patients with single-port thoracoscopic surgery for non-small cell lung cancer based on nomogram. Journal of Clinical Military Medicine. 2023;51(9):924-926.